Eurospital

Dequadin 0.25mg Tablets

Stomatitis Treatment Tonsillitis; 20 tablets

Active principles

DEQUADIN 0.25 mg tablets Each tablet contains: Active ingredient: 0.25 mg dequalinium chloride. Excipients: sucrose, glucose.

Excipients

DEQUADIN 0.25 tablets Sucrose, citric acid monohydrate, gelatin, glucose, magnesium stearate, mint essence, lime flavor.

Therapeutic indications

Tablets: Topical treatment in angina, stomatitis, pharyngitis and tonsillitis. After dental extractions DEQUADIN tablets are useful for the prophylaxis of infections.

Contraindications

Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. In children under the age of three, especially if predisposed to laryngospasm or convulsions.

Dosage

DEQUADIN tablets: Adults: slowly dissolve one tablet in the mouth every two or three hours during the initial phase of treatment, later the interval may be increased. Children over the age of three: 3 to 4 tablets per day. Do not exceed the recommended dose.

Warnings and Precautions

The use, especially if prolonged, of products for topical use can give rise to sensitization phenomena; if this occurs, treatment must be suspended and appropriate therapy instituted. The same applies to the development of resistant microorganisms. Oromucosal Spray and Oromucosal Solution: Use should be limited to lesions of the mouth and throat.

Interactions

Avoid the simultaneous use of other antiseptics and detergents.

Side effects

The use of the medicine can cause local irritation. Reporting of suspected adverse reactions Reporting suspected adverse reactions that occur after authorization of the medicinal product is important, as it allows continuous monitoring of the benefit / risk ratio of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.agenziafarmaco.gov.it/it/responsabili.

Pregnancy and breastfeeding

There are no known contraindications.